Skip to main content

eXoZymes Inc.

corporate_fare Company Profile

eXoZymes Inc.

EXOZ·NASDAQ·Life Sciences·CIK 0002010788

eXoZymes, Inc. is a development stage biotechnology company that focuses on creating enzyme modules and cell-free exozyme biosolutions. These solutions are designed for use in synthetic biology manufacturing. The company, which was incorporated in 2014, changed its name from Invizyne Technologies, Inc. to eXoZymes, Inc. in February 2025. Its headquarters are located in Monrovia, California.

eXoZymes Inc. (NASDAQ:EXOZ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for EXOZ at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • EXOZYMES INC. Files $50M Universal Shelf Registration Amidst Going Concern Doubt

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$9.16M
Diluted EPS
-$1.09
Op. Cash Flow
-$6.5M
Free Cash Flow
-$6.67M
Operating Income
-$9.72M
Cash & Equivalents
$3.04M
Debt / Equity
0.00×
Shares Outstanding
8.41M sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013563
$3.4 -0.87% today
52-week range · as of 2026-11-13 $3.24 – $18.4
Market cap
$27.42M
Volume
10.8K (0.8× avg)
3-mo avg 14.4K
Live data · 2026-11-22 12:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed EXOZ - Filings & News (Page 2)

EXOZ
Jan 16, 2026, 3:46 PM EST
Filing Type: S-3
Importance Score:
9
Price at Filing: $10.60
Real-time Price: $3.40 info
Change: -$7.20 (-68%) info
Market Cap: $27.423M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets